Table 1 Demographic and clinical characteristics of the RA patients enrolled in the study
Variables | N = 50 |
|---|---|
Clinical parameters | |
 Age. years | 40.0 ± 6.0 |
 Disease duration. Years | 10.8 ± 4.8 |
 Disease activity score-28 (DAS-28) | 2.7 (2.1; 3.1) |
  Remission. N(%) | 27 (54%) |
  Mild disease activity. N(%) | 5 (10%) |
  Moderate disease activity. N(%) | 17 (34%) |
  High disease activity. N(%) | 1 (2%) |
 SDAI | 10.9 ± 8.2 |
  Remission. N(%) | 9 (18%) |
  Mild disease activity. N(%) | 18 (36%) |
  Moderate disease activity. N(%) | 20 (40%) |
  High disease activity. N(%) | 3 (6%) |
 Hand Grip. N | 18.0 ± 7.3 |
 Current Treatment | |
  Glucocorticoids. N(%) | 31 (62%) |
  conventional DMARDs. N(%) | 47 (94%) |
  biological DMARDs. N(%) | 21 (43%) |
 HAQ | 0.9 ± 0.7 |
Laboratory Parameters | |
 ESR. mm/h | 13.9 ± 12.2 |
 CRP. mg/L | 5.6 ± 7.5 |